Remepy Revenue
Biotechnology Research • 
Manhattan, New York, United States • 51-100 Employees
Remepy revenue & valuation
| Annual revenue | $5,047,745 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $16,200,000 |
| Total funding | $10,000,000 |
Key Contacts at Remepy
Amir Amedi
Co-Founder And Chief Scientific Officer
Or Shoval
Co-Founder & Co-Ceo
Bar Nathansohn-Levi
Director Of Immunology
Shira Molcho
Medical Director
Daniella Perry Ziv
Senior Director Of Therapeutics
Jonathan Sandler
Director Of Quality
Brett Colbert
Director, Clinical Development And Medical Affairs
Merav Catalogna
Director Of Neuroscience
Ariel Shahaf
Director Of Therapeutics
Company overview
| Headquarters | Manhattan, New York, United States |
| Website | |
| NAICS | 541714 |
| Keywords | Oncology, Biotech, Pharma, Drug Development, Mobile Apps, Software, Neurology, Digital Health, Immunology |
| Founded | 2022 |
| Employees | 51-100 |
| Socials |
Remepy Email Formats
Remepy uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@remepy.com), used 40% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@remepy.com | 40% |
{first initial} | j@remepy.com | 37.5% |
{first name} | john@remepy.com | 20% |
{first initial}.{last name} | j.doe@remepy.com | 2.5% |
About Remepy
Remepy is Pioneering Hybrid Drugs™. Many medical conditions are better treated by combining pharmaceutical and non-pharmaceutical treatments. Hybrid drugs are a new type of drug asset, that combines traditional drugs with proprietary treatment protocols delivered measured and adapted using our AI capabilities. Remepy’s Digital Molecules™ are designed to be the software apps within Hybrid Drugs™. They are based on digital interventions and treatment protocols that are tailored to each medical condition and its corresponding drug and are constantly measured and tracked and personalized using advanced AI capabilities. The Digital Molecules™ enhance brain functions that balance the patient's neuro-endocrine and neuro-immunological systems and boost brain neuroplasticity, in order to optimize drug performance. We also address physical, motor, psychological, and behavioral symptoms Remepy partners with pharma companies to bring Hybrid Drugs™ to market that will combine Remepy’s Digital Molecule™ and traditional drug components.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Remepy has 35 employees across 11 departments.
Departments
Number of employees
Remepy Tech Stack
Discover the technologies and tools that power Remepy's digital infrastructure, from frameworks to analytics platforms.
CDN
CDN
JavaScript libraries
Tag managers
Hosting
Ecommerce
Miscellaneous
Security
Miscellaneous
Page builders
JavaScript libraries
Miscellaneous
Spain
France
Canada
Australia
United Kingdom
Lithuania
Frequently asked questions
4.8
40,000 users
